Prof Richard Sullivan (Kings College London, London, UK) and Emily Kobayashi (Senior Director, The Clinton Health Access Initiative) discuss the cancer access partnership and its initiative to improve access to quality-assured anti-cancer medicines.

She initially talks about the market failure in low-resource settings that create inaccessibility to high-quality cancer treatments in LMICs.

Ms Kobayashi then explains the cancer access partnership's history, its main goals and what they have done so far to improve access to quality cancer care. She also talks about the future plans to increase availability.

Prof Sullivan and Ms Kobayashi discuss the challenges to improving access to essential cancer drugs and how they can be resolved.